Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
E-sea International (Beijing) Biotechnology Co., Ltd. is a specialized medical technology company focused on the development and manufacturing of in vitro diagnostic (IVD) solutions. The company provides a comprehensive range of molecular diagnostic products, including automated nucleic acid extraction systems and real-time PCR detection kits for a variety of pathogens. Their portfolio primarily addresses clinical needs in infectious diseases, respiratory health, and reproductive medicine, with a strong emphasis on rapid and accurate testing. By integrating advanced molecular biology techniques with automated instrumentation, E-sea International delivers high-sensitivity diagnostic tools to hospitals, clinical laboratories, and research institutions globally. The company maintains international quality standards, including ISO 13485 certification and CE marking for many of its products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on E-sea International.